Key facts
- It has raised $12.5M; the latest was Later Stage VC in Sep 2025.
- Notable investors include US National Science Foundation, United States Department of War, Village Global, Knockout Capital, rpv — 26 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 26 names
- ·Watchlist + deal alerts for Atom (Therapeutic Devices)
- ·The full record, as it builds
Funding rounds
No funding rounds for Atom (Therapeutic Devices) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Atom (Therapeutic Devices)
Developer of mind-controlled bionic arms designed to help under-elbow amputees regain mobility. The company's bionic arms involve implanting electrodes that pick up on the brain's signals and help people to move, feel, and use the new limb in an intuitive, natural way, enabling researchers, amputees, and hobbyists to customize bionic hands for various purposes.
- Sector
- Healthcare
- HQ
- Palo Alto, CA, United States
- Founded
- 2019
- Employees
- 10
- Website
- atombodies.com/
- Ownership
- Privately Held (backing)
Atom (Therapeutic Devices) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Atom (Therapeutic Devices) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Atom (Therapeutic Devices) in its N-PORT filings yet. We sweep new filings monthly.